Laura Solforosi

Leiden, ZH 2333CN, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.

The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Journal: Vaccines
Published: March 15, 2024

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.

Journal: Nature
Published: May 31, 2023

Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT.

Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT.

Journal: Blood
Published: May 26, 2023

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans.

Journal: Frontiers in immunology
Published: May 01, 2023

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates.

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates.

Journal: The Journal of pharmacology and experimental therapeutics
Published: January 23, 2023

Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.

Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.

Journal: Nature communications
Published: October 26, 2022

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels.

Journal: Vaccines
Published: June 30, 2022

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Journal: NPJ vaccines
Published: March 25, 2022

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

Journal: Nature communications
Published: February 16, 2021

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Journal: The Journal of experimental medicine
Published: December 31, 2020

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Journal: NPJ vaccines
Published: June 26, 2020

A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus.

A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus.

Journal: Journal of theoretical biology
Published: November 18, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026